Anti-Aging

Post-GLP-1 Face and Body Restoration

Combined aesthetic planning after GLP-1-associated weight loss

시술 시간

진찰30-60분+시술 내용에 따름

다운타임

시술 내용에 따름

권장 횟수

3-6개월単位で段階設計

이 치료에 대해

After GLP-1 receptor agonist-associated weight loss, more patients present with facial fat loss, hollowing, laxity, neck/arm/abdominal looseness and reduced muscle mass. This is a protocol rather than one product, combining fillers, biostimulators, RF/HIFU, muscle stimulation, nutrition and resistance training planning.

작용 기전

After weight stabilizes, deep support may be addressed with HA/CaHA/PLLA, skin quality with PN/HA/laser, laxity with RF/HIFU and body changes with muscle stimulation or contouring. Avoid overcorrection during active weight loss.

적응증

일반 적응증(상세 설명 참고)처짐·윤곽

기대 효과

Planning is best after weight has stabilized for 3-6 months. Demand is rising rapidly in 2026, but protocols require individualization.

임상 근거

Allergan Aesthetics / AAD investigators (2026)

Population trends in facial aesthetic concerns among GLP-1 agonist patients. AAD Poster / company release

해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).

McKinsey (2025)

GLP-1s are boosting demand for medical aesthetics. Industry provider survey

해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).

Aesthetic surgery review authors (2026)

Nonsurgical aesthetic treatment of the face and neck in GLP-1-associated weight loss. Aesthet Surg J Open Forum

해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).

위험 및 부작용

Overcorrection during active weight loss, filler excess, unnatural contour and missed malnutrition or lean-mass loss are risks. Coordination with the weight-loss prescriber is preferred.

이 치료에 관심이 있으신가요?

AI 피부 진단으로 현재 피부 상태를 확인해 보세요

AI 피부 진단 받기 예약하기

다른 치료 보기

LaserPicoSure Pro자세히 보기 LaserFractional Laser자세히 보기 LaserPhotofacial IPL (Stellar M22)자세히 보기 Anti-AgingThermage FLX자세히 보기